Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
20 a » 20 _ (Expand Search), 20 μ (Expand Search), 20 c (Expand Search)
Showing 1,041 - 1,060 results of 74,577 for search '(( 20 a decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 0.93s Refine Results
  1. 1041
    Simulation waves of <i>V</i><sub><i>b</i></sub> and <i>i</i><sub><i>r</i></sub>, output voltage and current, <i>V</i><sub><i>o</i></sub> and <i>I</i><sub><i>o</i></sub>, and input current <i>i</i><sub><i>Ls</i></sub>.

    Simulation waves of <i>V</i><sub><i>b</i></sub> and <i>i</i><sub><i>r</i></sub>, output voltage and current, <i>V</i><sub><i>o</i></sub> and <i>I</i><sub><i>o</i></sub>, and input... by M. Zakir Hossain (6033752)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 1042
    Decoding of V1 neuronal responses predicts that perceptual discrimination of orientation will decrease as stimulus onset asynchrony (SOA) approaches zero.

    Decoding of V1 neuronal responses predicts that perceptual discrimination of orientation will decrease as stimulus onset asynchrony (SOA) approaches zero. by Katrina Louise Dell (6000422)

    Published 2018
    Save to List
    Saved in:
  3. 1043
    Cytokine concentrations in cord blood.

    Cytokine concentrations in cord blood. by Machiko K. Asaka (18334223)

    Published 2024
    “…In the present study, we investigated the potential association between cytokine concentrations in umbilical cord serum with any of the five classes of neurodevelopmental trajectories previously assigned, as follows: high normal (N = 85, 13.0%), normal (N = 322, 49.1%), low normal (N = 137, 20.9%), delayed (N = 87, 13.3%), and markedly delayed (N = 25, 3.8%) in infancy. …”
    Save to List
    Saved in:
  4. 1044
    Minimal underlying data set.

    Minimal underlying data set. by Machiko K. Asaka (18334223)

    Published 2024
    “…In the present study, we investigated the potential association between cytokine concentrations in umbilical cord serum with any of the five classes of neurodevelopmental trajectories previously assigned, as follows: high normal (N = 85, 13.0%), normal (N = 322, 49.1%), low normal (N = 137, 20.9%), delayed (N = 87, 13.3%), and markedly delayed (N = 25, 3.8%) in infancy. …”
    Save to List
    Saved in:
  5. 1045
    Trade-offs between suppressing cheaters and decreasing the time to stochastic clearance of a pure producer population, as controlled by <i>K</i><sub><i>a</i></sub>, are present for λ<sub>0</sub> > 0 but absent when λ<sub>0</sub> = 0.

    Trade-offs between suppressing cheaters and decreasing the time to stochastic clearance of a pure producer population, as controlled by <i>K</i><sub><i>a</i></sub>, are present for... by Alexander S. Moffett (8250291)

    Published 2022
    Save to List
    Saved in:
  6. 1046
    Image 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  7. 1047
    Table 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx

    Table 1_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  8. 1048
    Image 2_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 2_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  9. 1049
    Image 4_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 4_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  10. 1050
    Image 9_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 9_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  11. 1051
    Image 8_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 8_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  12. 1052
    Image 7_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 7_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  13. 1053
    Image 11_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 11_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  14. 1054
    Table 1_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx

    Table 1_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.docx by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  15. 1055
    Image 3_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif

    Image 3_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  16. 1056
    Image 6_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 6_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  17. 1057
    Image 10_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 10_The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  18. 1058
    Image 3_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif

    Image 3_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  19. 1059
    Image 6_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 6_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:
  20. 1060
    Image 7_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff

    Image 7_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. …”
    Save to List
    Saved in:

Search Tools: